Pre-submission meetings with the US FDA are popular among complex generic sponsors, but there are questions about how best to make them part of the product development process, since it appears even companies are having trouble fitting them into their schedules.
"A current challenge is how industry will integrate product development and pre-submission meetings into a product development timeline," according the minutes of a Jan. 10 meeting between FDA officials...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?